Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-1.150%
-0.05
-1.150%
-

-

 
07:44 / Stuttgart Stock Exchange WKN: A3CSFJ / Name: Aramis Group Sas / Stock / ? /

Aramis Group Sas Stock

A loss of -1.150% shows a downward development for Aramis Group Sas.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Aramis Group Sas stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Aramis Group Sas in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Analyzing the financial performance of Aramis Group SAS opens the door to some intriguing insights. The data reflects a company navigating through some choppy waters, marked by substantial revenue figures but grappling with challenges in profitability. Notably, the current market capitalization stands at approximately $394.7 million, which positions the company in a competitive spot within the industry, but raises questions about its overall sustainability and growth trajectory moving forward.

There are several pros and cons worth discussing. Let's dive into a comprehensive evaluation of the financials.

Strong Revenue Generation: Aramis Group reported trailing twelve months (TTM) revenue of approximately $2.1 billion. This reflects a healthy scale of operations, suggesting that the company has been able to capture significant market share and generate consistent sales.